P

ProQR Therapeutics NV
D

PRQR

2.64000
USD
-0.01
(-0.19%)
مفتوح الان
حجم التداول
5,641
الربح لكل سهم
-0
العائد الربحي
-
P/E
-8
حجم السوق
278,535,200
أصول ذات صلة
    A
    AXSM
    -3.940
    (-4.34%)
    86.900 USD
    C
    CRBP
    0.040
    (0.31%)
    13.000 USD
    C
    CYTK
    -0.260
    (-0.53%)
    48.630 USD
    G
    GLPG
    0.270
    (1.01%)
    27.000 USD
    NVS
    NVS
    0.450
    (0.46%)
    97.520 USD
    S
    SAGE
    -0.16000
    (-2.85%)
    5.45000 USD
    V
    VKTX
    -0.640
    (-1.51%)
    41.630 USD
    المزيد
الأخبار المقالات

العنوان: ProQR Therapeutics NV

القطاع: Healthcare
الصناعة: Biotechnology
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.